Sequence‐Defined Short Peptide‐Derived Coacervate Vesicles for Targeted Therapeutics
Advanced Materials · 2026-08 · 38 (44)
DOI: 10.1002/adma.73804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 06.07.2026. Verfasst von Sandip Sarkar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences and Center for Advanced Functional Materials, Indian Institute of Science Education and Research (IISER) Kolkata, Moh…. Hauptthemen laut MEDLINE: Peptides, Drug Carriers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: ANRF J.C. Bose Fellowship, MoE-STARS, SERB/ANRF.
Abstract (Originalsprache)
Compartmentalization underpins biological organization and the design of programmable therapeutic carriers. Here, we report a sequence‐defined short peptide, Biotin‐Ser(‐OPO 3 2 − )‐Phe‐Phe‐Arg ( Biotin‐SR ), that undergoes physiological liquid–liquid phase separation to form lipid‐free coacervate vesicles (CVs) with enhanced structural persistence. The designer peptide integrates oppositely charged functionalities that drive pH‐responsive coacervation, incorporating an alkaline phosphatase (ALP)‐cleavable anionic phosphoester, a diphenylalanine motif that promotes hydrophobic packing, and a cationic guanidinium group that stabilizes the coacervate architecture while serving as a precursor for nitric oxide (NO) generation. These CVs selectively target cancer cells via biotin‐mediated recognition. CVs of Biotin‐SR with pronounced morphological persistence, as confirmed by restricted molecular exchange in FRAP analysis, and encapsulate glucose oxidase (GOx) within this stabilized vesicular architecture, undergo ALP‐induced enzymatic dephosphorylation in ALP‐rich tumor environments to trigger an irreversible loss of charge complementarity, GOx release and a synergistic therapeutic cascade integrating enzymatic starvation, oxidative stress amplification, and NO‐mediated mitochondrial dysfunction. The resulting glucose depletion couples with NO generation to elevate reactive oxygen species (ROS), inducing mitochondrial dysfunction and suppressing tumor growth in both spheroids and xenograft models. This work demonstrates how minimal peptide sequences can translate liquid‐liquid phase separation into stable coacervate vesicles with enzyme‐responsive supramolecular function for targeted therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences and Center for Advanced Functional Materials, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur, West Bengal, India.
- Department of Bioscience & Bioengineering, Indian Institute of Technology, Jodhpur, Rajasthan, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur, West Bengal, India.
- Technical Research Centre, S. N. Bose National Centre for Basic Sciences, Kolkata, India.
ORCID-Profile: Atin Chatterjee, Nityananda Biswas, Raviranjan Pandey, Uttam Pal, Surajit Ghosh, Amitava Das
Förderung
- ANRF J.C. Bose Fellowship
- MoE-STARS
- SERB/ANRF
- UGC-India
- CSIR-India
- MHRD-India
- Department of Biotechnology, Government of India
- SERB Ramanujan Fellowship
Zitieren
APA
Sarkar, S., Roy, R., Chatterjee, A., Biswas, N., Pandey, R., Dey, S., Jana, B., Pal, U., Ghosh, S., & Das, A. (2026). Sequence‐Defined Short Peptide‐Derived Coacervate Vesicles for Targeted Therapeutics. Advanced Materials, 38(44). https://doi.org/10.1002/adma.73804
Vancouver
Sarkar S, Roy R, Chatterjee A, Biswas N, Pandey R, Dey S, et al. Sequence‐Defined Short Peptide‐Derived Coacervate Vesicles for Targeted Therapeutics. Advanced Materials. 2026;38(44). doi:10.1002/adma.73804
BibTeX
@article{Sarkar2026,
author = {Sarkar, Sandip and Roy, Rajsekhar and Chatterjee, Atin and Biswas, Nityananda and Pandey, Raviranjan and Dey, Shubhajit and Jana, Batakrishna and Pal, Uttam and Ghosh, Surajit and Das, Amitava},
title = {Sequence‐Defined Short Peptide‐Derived Coacervate Vesicles for Targeted Therapeutics},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {44},
doi = {10.1002/adma.73804}
}
EUVIMED